Due to the expression of surface death receptor DR4 and DR5 (Figure 1B), TRAIL showed cytotoxicity in these CRC cells, which might overcome chemotherapeutic MDR of CRC cells. Here, TNFSF10 is linked to colorectal carcinoma.